PILA PHARMA is a privately held clinical stage pharmaceutical company based in Malmö, Sweden.
PILA PHARMA is developing a novel type of oral anti-diabetic agent: a TRPV1 antagonist for the treatment of diabetes.

The company owns issued use-patents giving the right to treat diabetes and obesity with TRPV1 antagonists.
Our safe clinical development candidate, XEN-D0501, entered the first clinical trials in type-2 diabetic patients in 2017.

TRPV1_Artikel_2

We are extremely proud to inform you that, as of today, our Opinion and Concept Paper on the role of TRPV1 in diabetes is finally published in Trends in Molecular Medicine!

Read the paper here

(11-Nov-2017)
Meet us at
ConnectSverige

Connect Sverige
Skånes mest spännande Life-Science bolag pitchar

Lund, Sweden
November 17, 2017
Connect Sverige

Nordea

Nordea Markets

Copenhagen, Denmark
November 20, 2017
Nordea Markets

NFIM17

Nordic Female Investor Meeting 2017

Malmö, Sweden
November 21, 2017

NFIM17

Business Sweden

French-Swedish Life Science Day 2017

Paris, France
December 14, 2017
French-Swedish Life Science Day 2017

Interview
Dorte_X_Gram

Uppstickaren som vill ta plats i läkemedelsindustrin.
An interview with CEO Dorte X. Gram published in ‘DI Almedalen, Distributed with Dagens Industri, Sweden.

Read the article in Swedish here

(03-Jul-2017)
affarslivet

We are proud to be on the cover of the June 2017 issue of Affärslivet Norden, Medicine and Science magazine that focuses on innovation.
The magazine was distributed with Svenska Dagbladet.

Read the article in Swedish here
Read the magazine in Swedish here

(22-Jun-2017)
Dorte_x_Gram_Malmo

Stora förhoppningar på nytt effektivt läkemedel mot diabetes typ 2.
An interview with CEO Dorte X. Gram  published in ‘Analys Öresund’, Distributed with Dagens Industri, Sweden.

Read the article in Swedish here
Read the magazine in Swedish here

(15-Jun-2017)
DorteX Gram

“Min uppfinning kom och hämtade tillbaka mig”
Dr. Dorte X. Gram, CEO of PILA PHARMA was interviewed by Sydsvenskan, Sweden.

Read the article in Swedish here

(04-Dec-2016)
01-omslag-nordic-life-science-nr-03-2016

We are proud to be on the cover of the September 2016 issue of Nordic Life Science Magazine as representatives of Nordic Life Science companies.

Read the article here
Read the magazine here

(09-Sep-2016)

At BioEurope Spring in Stockholm in April 2016 Dr. Dorte X. Gram, CEO of PILA PHARMA was interviewed by the organizers about the current status and our plans going forward.

Please find the links below:
partnering360.com

(08-Apr-2016)
pila_modernamuseet

Investor presentation at ‘Next Big Thing’ (by Blasieholmen Investment Group)
Moderna Museet, Stockholm, Sweden

Watch the presentation here
Direct link to presentation here

(02-Dec-2016)